173 related articles for article (PubMed ID: 1698429)
1. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension.
Scott JP; Higenbottam T; Wallwork J
Br J Clin Pract; 1990 Jun; 44(6):231-4. PubMed ID: 1698429
[TBL] [Abstract][Full Text] [Related]
2. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
Andreassen AK; Madsen S; Kjekshus J; Simonsen S
Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
5. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
6. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
7. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
Krowka MJ; Frantz RP; McGoon MD; Severson C; Plevak DJ; Wiesner RH
Hepatology; 1999 Sep; 30(3):641-8. PubMed ID: 10462369
[TBL] [Abstract][Full Text] [Related]
8. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
N Engl J Med; 2000 Jun; 342(25):1866-70. PubMed ID: 10861321
[TBL] [Abstract][Full Text] [Related]
11. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
[TBL] [Abstract][Full Text] [Related]
13. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
Kramm T; Eberle B; Guth S; Mayer E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
[TBL] [Abstract][Full Text] [Related]
14. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease.
Gorenflo M; Gu H; Xu Z
Cardiology; 2010; 116(1):10-7. PubMed ID: 20424447
[TBL] [Abstract][Full Text] [Related]
15. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
[TBL] [Abstract][Full Text] [Related]
16. [Long-term treatment of primary pulmonary hypertension with inhaled iloprost].
Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
Pneumologie; 2001 Jan; 55(1):38-43. PubMed ID: 11236355
[TBL] [Abstract][Full Text] [Related]
17. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
18. [Aerosolized iloprost combined with a phosphodiesterase inhibitor in the treatment of primary pulmonary hypertension].
Isa R; Castro P; Martínez A
Rev Med Chil; 2004 Mar; 132(3):353-6. PubMed ID: 15376573
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.
Higenbottam TW; Butt AY; Dinh-Xaun AT; Takao M; Cremona G; Akamine S
Heart; 1998 Feb; 79(2):175-9. PubMed ID: 9538312
[TBL] [Abstract][Full Text] [Related]
20. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.
Stricker H; Domenighetti G; Fiori G; Mombelli G
Schweiz Med Wochenschr; 1999 Jun; 129(24):923-7. PubMed ID: 10413827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]